CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Net Revenues	$ 244,315	$ 37,594
Operating expenses:
Research and development	264,833	258,259
Selling, general and administrative	1,361,280	1,479,203
Total operating expenses	1,626,113	1,737,462
Operating loss	(1,381,298)	(1,699,868)
Other income (expense):
Change in fair value of derivative liabilities	0	1,761,726
Interest expense	(40,797)	(110,821)
Total other income (expense)	(40,797)	1,650,905
Net (loss)	$ (1,422,595)	$ (48,963)
Basic and diluted loss per common share	$ 0.00	$ 0.00
Basic and diluted weighted average shares outstanding	306,166,593	215,197,805